Quick answer
What is AOD9604?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works
AOD9604 is a peptide, grouped on this site under Growth hormone secretagogues, and the 11 research records kept here are 4 from studies in rats or mice and 7 that do not state what kind of study it is.
Every record the literature search returned for this name is kept here.
What it is
This site puts it in the Growth hormone secretagogues group.
A fragment of human growth hormone described in the retrieved records as its lipolytic domain; it is not reported to act at the growth hormone secretagogue receptor.[1, 2]
Stated in the titles of the cited 2001 Endocrinology and 2000 Hormone Research papers.
What kind of records
The records kept here are animal and laboratory studies only.
That sentence is produced by counting, not by reading. What was counted: no interventional human trial record; 4 rodent and 0 in vitro records among 11.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
The longer explanation
Where this comes from
The records cited above, in full.
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology (2001). pmid:11713213
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone research (2000). pmid:11146367